Colleran David bought ANIK
March 11, 2024 · Form 4 insider transaction
Colleran David bought 3,682 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,682
Price
$0.00
Total value
N/A
InsiderColleran David
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 11, 2024
Filing dateMarch 12, 2024
Shares owned after24,804
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.; Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 642 shares on May 12, 2023 and 192 shares on November 14, 2023.